Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.62+0.02 (+0.19%)
Close on Nov 18, 2026Market cap $893.06MP/E 13.8Yield –
Bioventus shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Bioventus's shares outstanding was 71M at Jun 27, 2026. For fiscal 2025 it was 69M, up 6.8% from the year before. The highest annual figure on record is 69M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 69M | +6.8% |
| FY2024 | Dec 31, 2024 | 65M | +3.0% |
| FY2023 | Dec 31, 2023 | 63M | +2.0% |
| FY2022 | Dec 31, 2022 | 61M | +35.0% |
| FY2021 | Dec 31, 2021 | 45M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 27, 2026 | 71M | +3.4% |
| Q1 FY2026 | Mar 28, 2026 | 70M | +6.1% |
| Q4 FY2025 | Dec 31, 2025 | 69M | +5.8% |
| Q3 FY2025 | Sep 27, 2025 | 69M | +5.5% |
| Q2 FY2025 | Jun 28, 2025 | 69M | +7.0% |
| Q1 FY2025 | Mar 29, 2025 | 66M | +4.1% |
| Q4 FY2024 | Dec 31, 2024 | 65M | +3.8% |
| Q3 FY2024 | Sep 28, 2024 | 65M | +3.9% |
| Q2 FY2024 | Jun 29, 2024 | 64M | +2.4% |
| Q1 FY2024 | Mar 30, 2024 | 63M | +2.0% |
| Q4 FY2023 | Dec 31, 2023 | 63M | +1.9% |
| Q3 FY2023 | Sep 30, 2023 | 63M | +1.9% |
| Q2 FY2023 | Jul 1, 2023 | 63M | +1.8% |
| Q1 FY2023 | Apr 1, 2023 | 62M | +2.7% |
| Q4 FY2022 | Dec 31, 2022 | 62M | +9.7% |
| Q3 FY2022 | Oct 1, 2022 | 62M | +47.4% |
| Q2 FY2022 | Jul 2, 2022 | 61M | +47.1% |
| Q1 FY2022 | Apr 2, 2022 | 60M | +44.7% |
| Q4 FY2021 | Dec 31, 2021 | 56M | – |
| Q3 FY2021 | Oct 2, 2021 | 42M | – |
| Q2 FY2021 | Jul 3, 2021 | 42M | – |
| Q1 FY2021 | Apr 3, 2021 | 42M | – |
See a number that looks wrong?